Tumor necrosis factor (TNF) is a macrophage product under active study as an anticancer drug. However, this agent can be very toxic and has been implicated in the pathogenesis of endotoxic shock. After intravenous injection of human recombinant TNF (4 ,ug/g), growing rats showed an unusual constellation of physiological responses, and all died within 2-4 hr. In 1 hr, TNF caused a sharp fall (2.5°C) in body temperature and a large increase in plasma prostaglandin E2 levels. Blood glucose initially increased, but then a profound hypoglycemia developed by 2 hr. The TNF-treated animals also showed diarrhea, cyanosis, and a severe metabolic acidosis. A single injection of the cyclooxygenase inhibitors indomethacin or ibuprofen before the TNF treatment completely prevented the rapid killing and reduced eventual lethality by 70%. These agents blocked prostaglandin E2 production and prevented the hypothermia, changes in blood glucose, acidosis, and other symptoms. Since similar physiological changes have been reported after endotoxin injection, our data support the suggestion that TNF production is a critical factor in the development of septic shock. These finding also indicate that increased production of prostaglandins or thromboxanes is important in endotoxic shock and argue that cyclooxygenase inhibitors should be useful in its therapy. Indomethacin did not block the cytotoxic effects of TNF in vito on several transformed cell lines (HeLa, Me 180, or L929). Therefore, combined use of TNF with a cyclooxygenase inhibitor may allow safer administaon of high doses of this polypeptide to cancer patients.
ABSTRACT
Tumor necrosis factor (TNF) is a macrophage product under active study as an anticancer drug. However, this agent can be very toxic and has been implicated in the pathogenesis of endotoxic shock. After intravenous injection of human recombinant TNF (4 ,ug/g), growing rats showed an unusual constellation of physiological responses, and all died within 2-4 hr. In 1 hr, TNF caused a sharp fall (2.5°C) in body temperature and a large increase in plasma prostaglandin E2 levels. Blood glucose initially increased, but then a profound hypoglycemia developed by 2 hr. The TNF-treated animals also showed diarrhea, cyanosis, and a severe metabolic acidosis. A single injection of the cyclooxygenase inhibitors indomethacin or ibuprofen before the TNF treatment completely prevented the rapid killing and reduced eventual lethality by 70%. These agents blocked prostaglandin E2 production and prevented the hypothermia, changes in blood glucose, acidosis, and other symptoms. Since similar physiological changes have been reported after endotoxin injection, our data support the suggestion that TNF production is a critical factor in the development of septic shock. These finding also indicate that increased production of prostaglandins or thromboxanes is important in endotoxic shock and argue that cyclooxygenase inhibitors should be useful in its therapy. Indomethacin did not block the cytotoxic effects of TNF in vito on several transformed cell lines (HeLa, Me 180, or L929). Therefore, combined use of TNF with a cyclooxygenase inhibitor may allow safer administaon of high doses of this polypeptide to cancer patients.
Tumor necrosis factor (TNF) is a protein produced in mononuclear phagocytes upon activation by endotoxin or other microbial products (1, 2) . TNF was originally identified by its ability to cause hemorrhagic necrosis in certain transplanted tumors, and it was subsequently shown to have cytotoxic and cytostatic effects on many transformed cells in culture (1, 3, 4) , but little or no toxicity on normal cells in vitro (3) (4) (5) (6) (7) . In addition, TNF and interferon-y are synergistic in their cytotoxic actions (5, (7) (8) (9) (10) (11) . TNF has been produced in large amounts by recombinant DNA techniques (12) (13) (14) (15) , and at present it is under active study for the treatment of human neoplasms. It is likely that TNF plays an important role in host defenses, such as in natural cytotoxic cell (16) and macrophage (17, 18) activities. However, its precise function in combating microbial infections or cancer is unclear.
TNF appears identical to a factor called "cachectin" that was purified by Beutler and Cerami from activated macrophages (19) (20) (21) by its ability to inhibit lipoprotein lipase (22) . Because crude preparations of cachectin inhibit differentiation of 3T3-L1 adipocytes in vitro (23) and can cause weight loss in mice (24) , these workers suggested that cachectin helps mobilize lipid stores during infections and is responsible for the marked weight loss (i.e., cachexia) that accompanies chronic disease. Our studies with recombinant TNF (I.C.K. and A.L.G., unpublished data), however, do not support a role for TNF in the muscle protein breakdown induced by endotoxin in vivo (25) or macrophage products in vitro (26) .
When injected, TNF can be highly toxic, and Beutler and colleagues (19, 27) have presented evidence that TNF is an important mediator in endotoxic shock. They showed that injection of mice with antibodies against TNF reduces the lethal effects ofhigh doses of endotoxin (19) . This finding also emphasizes the potential dangers inherent in treating human cancer patients with this polypeptide. In the course of studies on the possible role of TNF in muscle wasting, we noticed that when TNF is injected subcutaneously, the rats developed fever but grew normally (I.C.K. and A.L.G., unpublished data). However, when the same or higher doses were injected intravenously, the rats all died within several hours. We investigated further this lethal effect of TNF and attempted to define the physiological changes induced by this polypeptide and their relationship to the alterations seen in endotoxic shock. These studies implicate prostaglandins in mediating these toxic effects and suggest possible means for reducing the toxicity of administered TNF and for improved therapy of septic shock (28, 29 reflected changes in PGE2 release into plasma (32) . Arterial blood from the abdominal aorta was collected under ether anesthesia in heparinized syringes prior to CO2 analysis and blood pH measurements. The rectal temperature was measured with an electronic thermometer (model 49TA, Yellow Springs Instrument). All results are expressed as means ± SEM, and the statistical significance of changes seen were evaluated with the unpaired Student's t test. RESULTS
Lethal Effects of TNF and Protection by Cyclooxygenase Inhibitors. Intravenous injection of human recombinant TNF (4 ug/g) into the young growing rats caused death of all the animals within a few hours. In the first hour no deaths occurred, but thereafter, there was a progressive loss of viability ( Fig. 1 Upper). In a typical experiment, =20% of the animals that received TNF died in 2 hr, and by 4 hr all of this group were dead.
Because TNF stimulates PGE2 production in many cells and because inhibitors of arachidonic acid cyclooxygenase (i.e., prostaglandin synthase) can prevent fever induced with subcutaneous TNF (I.C.K. and A.L.G., unpublished data), we investigated whether such inhibitors could influence the TNF-induced lethality. When indomethacin was injected 2 hr before the TNF, it provided a dramatic protection against the rapid killing by TNF ( Fig. 1 Upper). Of the 20 animals that received a single injection of indomethacin prior to the TNF, all were alive 4 hr later, whereas all those receiving TNF alone had died (16/16) (Fig. 1 Upper). About one-quarter of the rats (7/20) 60 F 40 _ days. Not only did a single indomethacin injection prevent most of the mortality when given before the TNF, it also offered clear protection when injected 1 hr after the TNF (data not shown).
In animals treated with a single injection of ibuprofen, another cyclooxygenase inhibitor (Fig. 2 Upper), a clear protection against TNF was also observed, although this protective effect was smaller than that with indomethacin. About 75% of the ibuprofen-treated rats were still alive 6 hr after the TNF injection, and most of the animals (55%) were alive and appeared healthy after 24 hr. The greater protection afforded by indomethacin may be because this agent can inhibit other processes besides the cyclooxygenase (33) or because it inhibits the cyclooxygenase for longer periods than ibuprofen. In fact, ibuprofen provided a large protection initially, which decreased later (Fig. 2) as prostaglandin production returned to the original level (see below).
Because TNF stimulates PGE2 synthesis in several cell types (34) and because of this dramatic protection by the cyclooxygenase inhibitors (Fig. 1 Upper) , we attempted to measure body prostaglandin production after TNF injection by determining the levels of the stable metabolite of PGE2 (DHK-prostaglandin) in plasma. As shown in Table 1 , there was a very large (10-fold) increase in the blood content of DHK-prostaglandin within 1 hr after injection, and these high levels were maintained for several hours. Others have noted a similar dramatic increase in this metabolite of PGE2, as well as ofthromboxane B2 and 6-keto-PGF1a in endotoxin-treated animals (35, 36) . As expected, indomethacin and ibuprofen were found to block completely the large increase in the serum levels of DHK-prostaglandin. For example, in the rats that received indomethacin and TNF, this metabolite of PGE2 was extremely low (Table 1) 29 .50C and 320C. The dramatic fall in body temperature at 1 hr clearly preceded other toxic symptoms (see below) and thus seems to be a specific physiological effect of TNF rather than a consequence of the loss of viability. This hypothermic effect is particularly noteworthy since at lower intravenous doses, or when the same amount of TNF is injected subcutaneously, TNF induces a fever that can be blocked with cyclooxygenase inhibitors (I.C.K. and A.L.G., unpublished data).
The cyclooxygenase inhibitors also prevented the rapid fall in body temperature and the subsequent progressive hypothermia seen in the animals receiving only TNF. Of those treated with ibuprofen or indomethacin, several showed a slight fall in temperature (0.5(C-1TC), which quickly returned to normal levels ( Figs. 1 and 2) . If the indomethacin was injected 1 hr after the TNF (when hypothermia was already evident), it caused a rapid increase in body temperature toward normal and it reduced mortality. These findings suggest that some unidentified product of the cyclooxygenase reduces body temperature. This conclusion is quite surprising, since PGE2 has generally been associated with induction of fever (37) rather than with hypothermia, and inhibitors of prostaglandin synthesis are generally administered to combat fever.
One unusual response noted previously in experimentally induced endotoxic shock is an initial increase in plasma glucose followed by a severe hypoglycemia (28) that may be life threatening. Because of the possible role of TNF in mediating such effects, we measured the blood glucose content at different times after TNF injection. Large biphasic changes in blood glucose were found (Fig. 3) . Within 1 hr, a clear hyperglycemia developed, followed by a sharp decrease in plasma glucose levels to -30 mg per 100 ml (1.6 mM). By receiving indomethacin also did not show significant changes in plasma glucose levels (Fig. 3) , in sharp contrast to the large biphasic changes in the rats receiving TNF alone. Ibuprofen injection before the TNF also decreased the changes in blood glucose. After 4 hr, the surviving animals that had received TNF and ibuprofen had glucose levels -40% lower than the untreated control rats. However, this decrease was much less than that in animals treated only with TNF.
By 3 hr after TNF injection, the animals also showed a severe metabolic acidosis. Their arterial pH fell, their Pco2 decreased by -30%, and their arterial bicarbonate concentration was about one-half that in the controls (Table 2) . These changes are similar to those seen in patients with a severe acidosis due to septicemia, diabetes, shock, etc. The rats that received indomethacin before the TNF did not show a metabolic acidosis (Table 2) . Their blood bicarbonate levels were 50% higher than in animals that received only TNF, and 3 hr after TNF injection, their arterial Pco2 and pH were indistinguishable from those in control rats. Another symptom that became evident about 1 hr after TNF injection was diarrhea. In the hour before death, the animals appeared very lethargic and showed cyanosis in their extremities. None of these symptoms was evident in the rats that received indomethacin before the TNF. Both diarrhea and cyanosis have also been reported in experimental endotoxin-induced shock (38) (39) (40) .
Although these various toxic effects resemble ones reported in endotoxin shock ( 
DISCUSSION
TNF and the Physiology of Shock. It seems likely that TNF production plays an important protective role in combating microbial infections and neoplastic disease. Presumably, the benefits to the organism from TNF production must be rather large, since TNF is very toxic at high doses. This ability of TNF to kill rapidly ( Figs. 1 and 2 ) is probably due to multiple physiological actions, which seem to result from a dramatic increase in synthesis of prostaglandin and related metabolites ( Table 1 ). The drop in body temperature ( Figs. 1 and 2) , the hyperglycemia and subsequent hypoglycemia (Fig. 3) , the acidosis (Table 2) , diarrhea, and cyanosis could all be prevented by use of cyclooxygenase inhibitors. The crucial product(s) ofthis enzyme and their exact role in these various responses are completely unclear. However, it is noteworthy that administration to rats of high levels of PGE2 can cause diarrhea (A. Tashjian, personal communication), and prostaglandins have been reported to promote insulin release (44) . The apparent requirement for some prostaglandin or thromboxane for the lowering of body temperature is particularly intriguing (Fig. 2) and is without precedent in the literature. Obviously, the cyclooxygenase inhibitors should be very useful tools in clarifying the mechanisms responsible for these unusual pathologic responses.
The present findings provide strong support for the suggestion by Beutler and Cerami that TNF is a critical factor in the pathogenesis of septic shock (19, 20, 27) . Virtually all the physiological responses noted here after administering high concentrations of TNF were ones reported previously by one group or another upon endotoxin treatment of animals. For example, large increases in circulating prostaglandins have been reported in a variety of experimental models for shock (36, (45) (46) (47) (48) , and thromboxanes, PGI2, and PGE2 have also been proposed as important mediators of irreversible shock (35, 36, (45) (46) (47) (48) . Furthermore, administration of nonsteroidal anti-inflammatory drugs has been reported to improve survival and circulatory function in endotoxic and hemorrhagic shock (49, 50) . Even though these agents seem to reduce the lethal effects of endotoxin and TNF in animals, they have not been used clinically in shock patients (51) . The present findings provide a clear rationale for their usefulness in prevention or treatment of acute septic shock (43), since they clearly can block a number of life-threatening sequelae of high-circulating levels of TNF (Table 3) . In our studies, a single injection of cyclooxygenase inhibitors provided complete protection against the very rapid killing by TNF, although some ofthe treated animals (30o) died of unknown causes between 6 and 24 hr. Possibly, repeated administration of indomethacin or ibuprofen would have reduced this mortality further.
Thus even though activated monocytes can release many potent factors into the circulation, such as interleukin 1, overproduction of TNF may itself account for most of the life-threatening symptoms of irreversible shock. One surprising finding with TNF was the large fall in body temperature, since TNF itself is pyrogenic at low doses and since endotoxin elicits interleukin 1 production and fever (52) . Howev (Figs.  1 and 2 ) has also been observed in dogs receiving lethal doses of E. coli (41) . This phenomenon was attributed to impaired cardiovascular function (43, 53) leading to insufficient supply of substrates for heat production in peripheral tissues (54) . Although possible, the rapidity of the fall in temperature with TNF and its reversal by indomethacin suggest a more specific hypothermic mechanism perhaps mediated by an unidentified product of the cyclooxygenase pathways.
In the present studies, a severe metabolic acidosis was evident 3 hr after the TNF injection ( These findings argue that indomethacin may be useful in reducing the toxic effects of TNF without preventing its anti-neoplastic actions. This conclusion will have to be confirmed with various transplanted tumors in vivo, where direct cytotoxicity by TNF may not be the only mechanism contributing to its anti-neoplastic actions (e.g., local necrosis). Nevertheless, the findings in Fig. 4 emphasize that not all TNF effects involve prostanoids and suggest that combined administration of TNF and a cyclooxygenase inhibitor could enhance the therapeutic usefulness of TNF. This attractive possibility, as well as the possible use of such inhibitors in treating septicemia, should be tested systematically.
